Monday, 6 September 2021

Reuters Global Healthcare: Chilean health regulator approves CoronaVac use among children over age 6

Chilean health regulator approves CoronaVac use among children over age 6

The Chilean health regulator on Monday approved the COVID-19 vaccine produced by China's Sinovac Biotech Ltd for use in children over 6 years of age, allowing more people to be included in the country's rapid inoculation campaign.

Hundreds of health centres at risk of closure in Afghanistan - WHO

Hundreds of medical facilities in Afghanistan are at risk of imminent closure because the Western donors who finance them are barred from dealing with the new Taliban government, a World Health Organization official said on Monday.

UK announces extra 5.4 bln pounds to help COVID-hit health services

Britain will set aside a further 5.4 billion pounds ($7.5 billion) over the next six months to help its National Health Service cover additional costs from the COVID-19 pandemic and to tackle the huge treatment backlog.

G20 urges COVID help for poor states, but short on new commitments

The group of 20 rich countries said on Monday more efforts were needed to help poor countries vaccinate their populations against COVID-19, but steered clear of making new numerical or financial commitments.

UK records 41,192 new COVID cases on Monday

Britain recorded 41,192 new daily COVID-19 cases on Monday, up from 37,011 on Sunday, government statistics showed.

EU watchdog studying data on Pfizer COVID-19 vaccine booster dose

Europe's medicines regulator said on Monday it was evaluating data on a booster dose for Pfizer/BioNTech's , (22UAy.DE) COVID-19 vaccine, to be given six months after the second dose in people 16 years of age and older.

Denmark cancels tender for domestic coronavirus vaccine production

Denmark has cancelled its previously announced plans for a public tender to establish a national COVID-19 vaccine production facility as it bets on a vaccine already under development by a Danish firm, the Business Ministry said on Monday.

Sinovac booster shot reverses drop in antibody activities against Delta-study

A booster dose of Sinovac Biotech's COVID-19 vaccine reversed a decline in antibody activities against the Delta variant, a study showed, easing some concerns about its longer-term immune response to the highly contagious strain of the virus.

India's Hetero gets emergency use nod to make Roche's COVID-19 drug

Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.

BGI prenatal gene test under scrutiny for Chinese military links

Health regulators in five countries are examining a prenatal test that collects the DNA of women and fetuses for research, while some doctors that promoted it and clinics that sell it say they were unaware the company that produces it also conducts research with the Chinese military.

Related Videos

Only Pfizer to start U.S. booster plan -source

Number of dementia cases set to jump 40% by 2030

Can llamas' antibodies help fight COVID?